Every year, thousands of men in Spain face a prostate cancer diagnosis. Despite its high incidence, prostate cancer remains shrouded in taboos. It is the most common cancer among men in Spain, with approximately 30.000 new cases annually. Fortunately, advances in medicine and greater public awareness mean that what was once devastating news is now being addressed with very high cure rates thanks to early detection strategies.
The key to this therapeutic success lies in not waiting for the body to give warning signs, since this type of pathology is usually silent in its initial stages. When symptoms such as difficulty and pain when urinating , weak urine flow, or persistent pain in the pelvic area appear, the tumor is usually already in a more advanced stage. For this reason, specialists insist that the PSA test , a simple and non-invasive blood test, is the first essential step in winning the battle against time.
Hospital initiatives and access to screening
Several leading healthcare centers in Spain have taken advantage of key dates to open their doors and facilitate access to these tests. For example, at the Quirónsalud Toledo Hospital, priority pathways have been established so that men between 40 and 65 years old can have their prostate-specific antigen (PSA) levels checked without bureaucratic complications. These types of campaigns aim to reverse the low perception of risk that still persists among many men, offering individual assessments by family doctors and direct access to urology if the results require it.
Meanwhile, in Madrid's public healthcare system, La Paz Hospital has reinforced its message with campaigns encouraging men to overcome their fear of checkups. It's crucial to keep in mind that, although the general recommendation to begin screenings is at age 50, those with a direct family history should start at 45. Diagnostic accuracy has improved dramatically in these centers thanks to multiparametric magnetic resonance imaging and fusion biopsies, which pinpoint the problem with near-millimeter precision.
Technological innovation and the challenge of young patients
One of the aspects that most concerns the scientific community today is the increase in cases among patients under 55. Institutions like CRIS Cancer Foundation are funding large-scale projects to study the genetics of these early-stage tumors, which tend to be more aggressive. By analyzing the DNA of thousands of men, researchers hope to understand why certain genetic profiles predispose individuals to developing the disease at a young age, which would pave the way for even more personalized and effective treatments.
In the field of treatment, medicine no longer only seeks to eliminate the tumor, but also to preserve the patient's quality of life as much as possible. The use of robotic surgery, available at hospitals such as La Paz and Quirónsalud Infanta Luisa, allows for interventions of astonishing precision, drastically reducing traditional side effects and accelerating recovery. This is complemented by next-generation radiotherapy, known as SBRT, which delivers highly focused doses of radiation , protecting the healthy tissues surrounding the prostate.
Maintaining healthy lifestyle habits, such as following a proper diet for men over 50 , and keeping all recommended medical appointments are the best tools we currently have. Science continues to advance by leaps and bounds, but individual commitment to attending regular checkups remains the driving force behind saving thousands of lives each year in our country, transforming the prognosis of a disease that, when detected early, doesn't have to slow down our daily lives.
